Skip to main content
. 2021 Jan 2;73(9):e3428–e3434. doi: 10.1093/cid/ciaa1910

Table 1.

Baseline Demographics by Tuberculous Meningitis Diagnosis and Separately by Result on the FujiLAM Assay

Characteristic Definite or Probable TBM Not TBM P FujiLAM Positive FujiLAM Negative P
Age, years 33 (26–40) 37 (29–48) .04 32 (26–40) 37 (28–45) .04
Women, n (%) 21 (36) 16 (37) .9 12 (39) 25 (36) .8
MRC grade, n (%) .02 .01
 1 10 (17) 15 (44) 3 (10) 22 (36)
 2 35 (60) 16 (47) 20 (65) 31 (51)
 3 13 (22) 3 (9) 8 (26) 8 (13)
GCS <15 46 (79) 23 (55) .02 28 (90) 41 (59) .002
Headache symptom 51 (86) 32 (76) .3 27 (87) 55 (80) .6
Illness duration, days 30 (14–30) 21 (14–60) .39 30 (14–60) 24.5 (14–30) .23
CD4 T cells/µL 79 (30–260) 102 (45–232) .48 46 (18–86) 153 (45–273) .04
<100 CD4 cells/µL, n (%) 13 (57) 4 (44) .7 9 (82) 8 (38) .03
Pulmonary or extrapulmonary TB, n (%) 27 (47) 7 (16) .002 15 (48) 19 (27) .04
CSF WBC, cells/µL 65 (<5–245) <5 (<5–35) .003 87.5 (<5–240) <5 (<5–80) .03
CSF protein, mg/dL 116 (72–184) 74 (36–118) .02 119 (72–187) 99 (53–134) .2
CSF glucose, mg/dL 29 (19–68) 82 (65–107) <.001 22 (18–54) 75 (36–100) .005
CSF lactate, mmol/L 7.5 (3.9–9.5) 2.3 (2.0–3.1) <.001 9.5 (4.3–10) 2.9 (2–7.2) .002
14-Day mortality, n (%) 17 (29) 9 (21) .5 10 (32) 16 (23) .3

Data are presented as n (%) or medians with interquartile range. CD4 T-cell count was only available for the latter portion of the cohort (n = 32). Pulmonary or extrapulmonary TB is based upon detection by Xpert Ultra or AlereLAM in sputum or urine, or suggestive chest radiography or abdominal ultrasound. Abbreviations: CSF, cerebrospinal fluid; FujiLAM, Fujifilm SILVAMP TB LAM; GCS, Glasgow Coma Scale; MRC, British Medical Research Council grade for TBM (this grade was available for n = 92 participants); TB, tuberculosis; TBM, tuberculous meningitis; WBC, white blood cell count.